Han Kun facilitates AstraGenomics' strategic partnership with a global seed industry leader
October, 2024 - Beijing, Mainland China
In October 2024, AstraGenomics announced its strategic alliance with a prominent player in the global seed industry. Han Kun Law Offices served as AstraGenomics' transactional and intellectual property (IP) legal advisor for the collaboration, providing comprehensive legal services.
About AstraGenomics
AstraGenomics is an innovative biotechnology company committed to advancing groundbreaking gene editing technologies. By establishing a cutting-edge intelligent platform that integrates "smart algorithms and high-throughput automated experiments," the company has developed diversified gene editing technologies, including an advanced large fragment gene writing system and a mini-nuclease system. Leveraging these varied tools and techniques, AstraGenomics has engaged in fruitful collaborations with global partners in various fields such as gene and cell therapy, modern agriculture, and biomanufacturing. AstraGenomics always takes the mission "to enhance human health and quality of life through innovations in genetic technology", and is dedicated to combating diseases, providing nutritious healthy food options, engineering microorganisms, optimizing resource utilization efficiency, and continuously promoting human well-being through its pioneering gene editing solutions.
